MarketLens
Sign Up

What Did Ascentage Pharma Present at ASCO 2026

3 months ago
SHARE THIS ON:

What Did Ascentage Pharma Present at ASCO 2026

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News2 weeks ago

Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML

Aptevo Therapeutics reported a 93% clinical benefit rate with its mipletamig triplet in frontline TP53-mutated AML patients, nearly doubling published ven/aza outcomes. The data could support further ...
Stock News1 months ago

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Ascentage Pharma's H1 2026 revenue rose 29% YoY to US$44.5M (RMB302.2M), driven by higher product sales. The company also expanded leadership with new Chief Business Officer and other executive appoin...
Stock News2 months ago

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

Zentalis will present overall survival data from the DENALI Part 1b study of azenosertib at ESMO 2026, October 23-27 in Madrid.

Breaking News

View All →

Top Headlines

View More →
Stock News59 minutes ago

United Parcel Service (UPS) Stock Slides as Market Rises: Facts to Know Before You Trade

Stock News1 hour ago

$500 a Month in Nvidia Stock Since ChatGPT Launched Is Now Worth About $79,000

Stock News1 hour ago

Microsoft (MSFT) Laps the Stock Market: Here's Why

Stock News1 hour ago

Amazon (AMZN) Laps the Stock Market: Here's Why

Stock News1 hour ago

Shopify to Use Meta's Muse for Agentic Checkout